Cargando…
Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience
Background: Antiviral treatment is a hot topic regarding therapy for COVID-19. Several antiviral drugs have been tested in the months since the pandemic began. Yet only Remdesivir obtained approval after first trials. The best time to administer Remdesivir is still a matter for discussion and this c...
Autores principales: | Simioli, Francesca, Nicoletta, Carmine, Valentino, Maria Rosaria, Martino, Maria, Annunziata, Anna, Carannante, Novella, Di Micco, Pierpaolo, Fiorentino, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464871/ https://www.ncbi.nlm.nih.gov/pubmed/34574882 http://dx.doi.org/10.3390/healthcare9091108 |
Ejemplares similares
-
Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series
por: Simioli, Francesca, et al.
Publicado: (2021) -
Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC
por: Annunziata, Anna, et al.
Publicado: (2021) -
Acute Pancreatitis and COVID-19: A Single-Center Experience
por: Annunziata, Anna, et al.
Publicado: (2021) -
Diagnosis and treatment of pneumonia, a common cause of respiratory failure in patients with neuromuscular disorders
por: Carannante, Novella, et al.
Publicado: (2021) -
Daytime alternatives for non-invasive mechanical ventilation in neuromuscular disorders
por: Annunziata, Anna, et al.
Publicado: (2021)